Heparin is an injectable blood thinner, utilized for the treatment of deep vein thrombosis (DVT) and pulmonary embolism. It is also employed as part of the treatment of unstable angina and myocardial infarction. The increasing incidence of coagulation disorders is propelling the demand for heparin significantly across the world.

Get Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=803

The global heparin market has been analyzed on the basis of product in this research report. Ultra-low molecular weight heparin (ULMWHs), low molecular weight heparin (LMWHs), and unfractionated heparin are the major products available in the worldwide heparin market. ULMWHs has been the most commonly used heparin over the past decade. However, the increasing overall cost of ULMWHs is likely to hamper the growth of this market segment in the near future, states the research report.

The report also studies the global heparin market on the basis of its regional spread. According to the study, Europe, North America, Asia Pacific, and the Rest of the World are the prime regional markets for heparin.

Europe dominated the global heparin market in 2014, while North America occupied the second position. The rising incidence of coagulation disorders in North America and Europe is driving these regional markets significantly.

In addition to this, the growing prevalence of deep vein thrombosis (DVT), spurred by the rapid increase in the geriatric population, leading to cancer, heart failure, and obesity is likely to drive the demand for heparin in these regions over the forecast period, notes the research study.

The heparin markets in Asia Pacific and the Rest of the World are also expected to exhibit healthy growth during the forecast period on account of the presence of a largely untapped market. Analysts at TMR anticipate the economic growth, the infrastructural development in the healthcare sector, and the rising number of surgical procedures in these regions to fuel the demand for heparin significantly in the coming years.

Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, Fresenius Kabi AG, Mylan N.V., Sanofi S.A., Pfizer Inc., and Syntex S.A. are some of the key participants in the global heparin market profiled in the report.

Browse Full Research Report: http://www.transparencymarketresearch.com/heparin-market.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.